Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.
National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, Pittsburgh, PA.
Patrick G
PG
Gavin
National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, Pittsburgh, PA.
Nan
N
Song
National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, Pittsburgh, PA.
S Rim
SR
Kim
National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, Pittsburgh, PA.
Katherine L
KL
Pogue-Geile
National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, Pittsburgh, PA soon.paik@nsabp.org.
Soonmyung
S
Paik
D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000235:genetics* / Q000276:immunology*; D005260:Female; D006801:Humans; D058990:Molecular Targeted Therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*
D061067:Antibodies, Monoclonal, Humanized; D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases